Ingevity Corp. (NGVT) intrinsic value & 10-year financials

Ingevity Corp. (NGVT) has a Graham intrinsic value of $67.19 per share. At $69.82 on Oct 17, 2026, the stock trades 4% above that value. Over the last 10 fiscal years revenue grew 2.8% a year to $1.2B, with an average return on invested capital of 20.4%.

Graham intrinsic value
$67.19
Share price (Oct 17, 2026)
$69.82
Price vs Graham value
4% above
Market cap
$2.5B
Revenue (FY2025)
$1.2B
Revenue growth (10-yr CAGR)
2.8%
ROIC (10-yr avg)
20.4%
Free cash flow (FY2025)
$273.5M

NGVT 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $1.2B -$167.1M -$4.61 $273.5M 35.9% 31.1%
FY2024 $1.4B -$430.3M -$11.85 $51.0M 26.2% 16.8%
FY2023 $1.7B -$5.4M -$0.15 $95.3M 23.5% 10.4%
FY2022 $1.7B $211.6M $5.50 $170.6M 27.1% 18.9%
FY2021 $1.4B $118.1M $2.95 $189.2M 30.3% 18.3%
FY2020 $1.2B $181.4M $4.37 $270.3M 32.7% 18.0%
FY2019 $1.3B $183.7M $4.35 $160.9M 30.7% 23.4%
FY2018 $1.1B $169.1M $3.97 $158.1M 23.2% 25.9%
FY2017 $972.4M $126.5M $2.97 $121.7M 20.8% 27.0%
FY2016 $908.3M $35.2M $0.83 $71.2M 18.0% 14.0%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

Ingevity Corp has demonstrated mature, steady growth, with revenue compounding at 2.8% annually over the past decade.

Ingevity Corp has earned high returns on invested capital, averaging 20.4% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.

Over the decade, Ingevity Corp shows that management has aggressively returned capital to shareholders by retiring 14.3% of outstanding shares, and that the company has leveraged its balance sheet to sustain operations.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, Ingevity Corp is modeled at 2.8% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $67.19 per share.

NGVT stock: frequently asked questions

What is the intrinsic value of Ingevity Corp. (NGVT) stock?

Using Benjamin Graham's revised formula, V = EPS × (8.5 + 2g) × 4.4 / Y, with reported diluted earnings per share, a 2.8% normalized growth rate (capped at 15%) and a 5.1% AAA corporate bond yield, NGVT's intrinsic value is about $67.19 per share.

Is NGVT stock undervalued?

At $69.82 (close on Oct 17, 2026), NGVT trades 4% above its Graham value of $67.19. On Graham's terms the shares look fully priced. A formula is a starting point for research, not a recommendation.

How fast has Ingevity Corp. grown?

Revenue went from $908.3M in fiscal 2016 to $1.2B in fiscal 2025, a compound annual growth rate of 2.8%. Net income was -$167.1M in fiscal 2025.

Does Ingevity Corp. generate free cash flow?

Ingevity Corp. generated $273.5M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 10 of the last 10 reported years.

What is NGVT's return on invested capital?

Average ROIC over the last 10 fiscal years was 20.4%, and average return on equity was 1.7%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this NGVT data come from?

From Ingevity Corp.'s annual 10-K filings on SEC EDGAR. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar chemicals & allied products stocks